Physician profile
Lynne Whyte
NPI 1679507131
$1,515.43
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $651 · 2020: $251 · 2021: $37.59 · 2022: $177 · 2023: $20.29 · 2024: $379.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $398.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $321.17 | 2019-2020 | |
| Kaleo, INC. | $181.95 | 2019-2024 | Auvi-Q |
| Glaxosmithkline, LLC. | $169.57 | 2020-2024 | Bexsero |
| Merck Sharp & Dohme LLC | $152.05 | 2019-2024 | Vaxneuvance, Gardasil 9, Gardasil |
| Corium, LLC | $143.41 | 2022-2024 | Azstarys |
| Adlon Therapeutics L.P. | $117.48 | 2019-2021 | |
| Sobi, INC | $69.42 | 2019 | |
| Avion Pharmaceuticals | $68.21 | 2019-2020 | |
| Pfizer INC. | $68.02 | 2019-2024 | |
| Teva Pharmaceuticals USA, INC. | $52.16 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $39.04 | 2019-2020 | |
| Noven Therapeutics, LLC | $23.71 | 2024 | Xelstrym |
| Hologic Sales and Service, LLC | $21.05 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $19.84 | 2019 | |
| Ironshore Pharmaceuticals INC. | $16.88 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $14.06 | 2019 | |
| Bausch Health US, LLC | $13.86 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $12.20 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lynne Whyte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.